Type 2 Diabetes Clinical Trials in Las Vegas, Nevada

5 studies are recruiting for type 2 diabetes in Las Vegas, Nevada right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

   This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join. The study has 3 parts. In each part the study compares survodutide with placebo. Surv…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Palm Research Center, Las Vegas, Nevada

   Locations

   121 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07754461 on ClinicalTrials.gov

2. Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

   CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in th…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Alliance Clinical - Las Vegas, Las Vegas, Nevada

   Locations

   61 in total

   Run by

   Sparrow Pharmaceuticals

   See if you can join NCT07296484 on ClinicalTrials.gov

3. AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

   This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diabetes who are at higher risk of heart and blood vessel problems and are already taking 1 to 3 diabetes medications. There are 2 study treatments in thi…

   Stage

   Phase 3

   Ages

   45 and older

   Site

   Palm Research Center Inc-Vegas, Las Vegas, Nevada

   Locations

   330 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07797335 on ClinicalTrials.gov

4. Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

   This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite Ozempic-based therapy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Excel Clinical Research, Las Vegas, Nevada

   Locations

   17 in total

   Run by

   Biomea Fusion Inc.

   See if you can join NCT07502508 on ClinicalTrials.gov

5. HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

   Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to ce…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas, Nevada

   Locations

   25 in total

   Run by

   Housey Healthcare ULC

   See if you can join NCT07546929 on ClinicalTrials.gov